FSRH and RCOG joint statement on Bayer’s decision to discontinue Essure® June 2017

ecd78fba3d82b5e57fe95b80085b035e

Published on: 9 June 2017

File size: 454kb PDF

File type: FSRH Policy and External Affairs

Essure® is a form of permanent female sterilisation which involves the hysteroscopic insertion of flexible micro-inserts into the proximal section of the fallopian tubes and is undertaken without general anaesthesia.

Download and read the statement in full.

Your download should start automatically. If not download directly.